SU 11248 (Sutent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SU 11248 (Sutent), covering 2020-02-25 to 2020-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years [Phase 1, Phase 2]